about
Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bitesHuman IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission AreaHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector controlNovel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites.Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector controlA multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.In silico identification of a candidate synthetic peptide (Tsgf118-43) to monitor human exposure to tsetse flies in West Africa.Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.Identification of a Tsal152-75 salivary synthetic peptide to monitor cattle exposure to tsetse flies.gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas.Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker.Evaluation of a real-time quantitative PCR to measure the wild Plasmodium falciparum infectivity rate in salivary glands of Anopheles gambiae.Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border.The Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.Improved accuracy of the transcriptional profiling method of age grading in Aedes aegypti mosquitoes under laboratory and semi-field cage conditions and in the presence of Wolbachia infection.First insights into the cattle serological response to tsetse salivary antigens: a promising direct biomarker of exposure to tsetse bites.Identification of Glossina palpalis gambiensis specific salivary antigens: towards the development of a serologic biomarker of human exposure to tsetse flies in West Africa.Human/vector relationships during human African trypanosomiasis: initial screening of immunogenic salivary proteins of Glossina species.Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to BitesEvaluation of Human Exposure to Bites in Rubber and Palm Cultivations Using an Immunoepidemiological BiomarkerExploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarkerUse of Anopheles salivary biomarker to assess seasonal variation of human exposure to bites in children living near rubber and oil palm cultivations in Côte d'IvoireRisk factors of exposure to Aedes albopictus bites in mainland France using an immunological biomarkerPattern of antibody responses to Plasmodium falciparum antigens in individuals differentially exposed to Anopheles bitesVectorial Transmission of Malaria in Major Districts of Côte d'IvoireRole of Anopheles gambiae s.s. and Anopheles coluzzii (Diptera: Culicidae) in Human Malaria Transmission in Rural Areas of Bouaké, in Côte d'Ivoire
P50
Q27489414-16F367D4-18E3-4C2B-AE67-88292AFE8527Q28119695-EAB1A11C-6DDE-4A9B-AD10-9CF75F89C465Q28744241-CE988B64-17F2-4243-9A3B-DE7545D35314Q33346270-F639E206-CF03-46D6-A1D6-C9DFAC43327DQ33855766-E06C22F4-A17B-41C3-92B9-B2480C0BFDF5Q34023538-FA14704F-DECD-47F6-8A1E-C7D7CA5CE6E8Q34030263-9C871536-EF6C-44F7-BD62-40DED1F4A65DQ34351117-320CFBEE-474C-467A-905B-B592ECF49FB7Q35006535-C73BF92D-44B3-454E-8D27-27A295A45FCDQ35880068-9B03EEB7-106A-487B-9A14-1CFD8854372EQ35916023-DBF3084C-6260-4E90-96AF-EE42DCC2B8ECQ36160018-B8C579C0-AB77-46DD-A9A2-9D41CF08AAEEQ36686937-A7C6D674-C67F-4052-8161-99C55CCFF043Q36780477-B2892DE3-7C5F-4B67-A4B8-B4727547B1D5Q36945208-2E599A56-D11A-4EE7-A9DA-129D70BF143FQ37000850-5CE9ABE8-3078-4AFE-AFDC-CBB83967CCFDQ37153769-1AD17DEE-8F4F-4C0F-9328-959E90920709Q39609570-1C2FB694-4E87-46AA-8D71-69212DEAAA41Q41502113-27D37AF0-2212-4B4E-A5D6-03103595BCA3Q43001865-8B1B8FBB-FD30-4FA5-8A71-C6F17D31BDEAQ43689282-650AEC1A-850C-4EA4-B787-3891113BD615Q43928690-4BB65EB8-7DED-423E-8C9A-13B4B779E025Q52676749-2A8222C4-5D03-48A4-A24A-31AED83A49FFQ56381103-95CF8BD4-0A7C-4E6C-9356-2B67DDF21339Q58792906-5D6F9C78-795C-4DAF-9E41-1E5969020344Q64108341-62B89AEF-E3B2-4088-A5AD-B777D3773C7EQ64122993-9016BA5F-643C-4036-A771-FCA648F305F5Q66679170-2DAF9775-5DD2-4C60-A474-5A72AC752B32Q89835598-B1E731B0-E675-49C0-989C-90FD440B2A2CQ91563287-4DEF6D25-10B3-470B-96AE-B0EC15BEF93BQ92946342-9CDA9ACB-5CC5-45CF-ACB1-AB68BD04C1CE
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anne Poinsignon
@ast
Anne Poinsignon
@en
Anne Poinsignon
@es
Anne Poinsignon
@nl
Anne Poinsignon
@sl
type
label
Anne Poinsignon
@ast
Anne Poinsignon
@en
Anne Poinsignon
@es
Anne Poinsignon
@nl
Anne Poinsignon
@sl
prefLabel
Anne Poinsignon
@ast
Anne Poinsignon
@en
Anne Poinsignon
@es
Anne Poinsignon
@nl
Anne Poinsignon
@sl
P106
P21
P31
P496
0000-0003-2921-4486